Gerrit Dispersyn is the founder of Phio Pharmaceuticals. Based in Marlborough, United States.
Gerrit Dispersyn is the President and CEO of Phio Pharmaceuticals, a biotechnology company focused on developing immuno-oncology therapeutics using its proprietary self-delivering RNAi (INTASYL™) platform. Under his leadership, the company has expanded its pipeline and initiated collaborations, including one with AgonOx, Inc., for cancer immunotherapies. Phio Pharmaceuticals completed two equity financings in Q1 2021, raising $21.7 million.
Full founder directory · Investor directory · Company funding database · Fundraising library